Fairmount Funds Management LLC
Spyre Therapeutics, Inc. · Director
Fairmount Funds Management LLC is listed in public filings as director. This Fairmount Funds Management LLC insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Spyre Therapeutics, Inc. (SYRE), Zenas BioPharma, Inc. (ZBIO), Viridian Therapeutics, Inc. (VRDN), Oruka Therapeutics, Inc. (ORKA), and Galecto, Inc. (GLTO). Investors use Fairmount Funds Management LLC's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $6.0M316.2k shares | BuyOct 7, 2025 | $19.00 | -- | |
| $3.0M150k shares | BuyMar 31, 2026 | $20.00 | -- | |
| $30M1.6M shares | BuySep 13, 2024 | $18.75 | -- | |
| $10.0M454.5k shares | BuyOct 23, 2025 | $22.00 | -- | |
| $20M1.2M shares | BuyMay 11, 2026 | $17.00 | -- | |
| $25M2.8M shares | BuyJul 10, 2025 | $9.00 | -- | |
| $127M3.5M shares | SellJan 22, 2026 | $36.40 | -- | |
| $243M7M shares | SellMar 31, 2026 | $34.66 | -- | |
| $134M1.8M shares | SellJan 22, 2026 | $76.30 | -- |